id,indicator_code,spatial_dim_type,iso_code,time_dim_type,region_code,region,dim1type,dim1,year,dim2type,dim2,dim3type,dim3,data_source_dim_type,data_source_dim,value,numeric_value,low,high,comments,date,time_dimension_value,time_dimension_begin,time_dimension_end,country,indicator_name,language,title
10157324,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.53,0.53,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
417164,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.10,11.1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
467452,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.51,3.51,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5468012,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FJI,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Fiji,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8715483,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.28,0.28,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5556850,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Pakistan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7218474,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8874090,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.33,8.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9121900,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HRV,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.11,11.11,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Croatia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4345238,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.60,5.6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7611968,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VEN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Venezuela (Bolivarian Republic of),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2790575,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7852955,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CZE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,10.00,10,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Czechia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9762905,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.20,8.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8195681,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,25.08,25.08,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6622402,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1971845,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.09,0.09,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
473835,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7155054,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LUX,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Luxembourg,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7428041,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.29,0.29,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2777971,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.69,4.69,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3063447,GASP_ISOLATESDSR_PROPORTION,COUNTRY,URY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,42.90,42.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Uruguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3165108,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.70,3.7,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8620398,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.28,3.28,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5677152,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,47.07,47.07,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4281921,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KEN,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Kenya,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9179137,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1064311,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9045816,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,14.06,14.06,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5867433,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.29,0.29,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2651067,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.75,8.75,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1051682,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.37,1.37,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2841598,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,60.04,60.04,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3108018,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.71,5.71,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9623443,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9929749,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.00,2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5030639,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8297353,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ECU,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Ecuador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2276613,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.40,3.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
892942,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,34.86,34.86,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2543394,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5975222,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1172352,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,78.57,78.57,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7827663,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.67,11.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,China,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9617108,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6609849,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.39,1.39,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3539240,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8544653,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,35.00,35,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2549792,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.12,1.12,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7662818,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,20.35,20.35,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6222805,GASP_ISOLATESDSR_PROPORTION,COUNTRY,EST,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Estonia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6368619,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,81.88,81.88,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6514619,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,58.40,58.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8170445,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Panama,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1781447,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2124298,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.10,8.1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Brazil,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5455516,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7123556,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,74.00,74,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
994587,GASP_ISOLATESDSR_PROPORTION,COUNTRY,TUN,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Tunisia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9198325,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9318810,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MMR,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Myanmar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6298785,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.99,0.99,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6533714,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARE,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.88,5.88,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United Arab Emirates,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2029078,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5632818,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,63.00,63,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5823130,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,21.35,21.35,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,China,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9261711,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.00,11,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4522983,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3012891,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,51.04,51.04,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Switzerland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4903776,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.59,0.59,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9775785,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
125616,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3437921,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8348066,GASP_ISOLATESDSR_PROPORTION,COUNTRY,RUS,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Russian Federation,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3653642,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.80,1.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2054505,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.00,3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2295759,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
905794,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2568908,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,10.71,10.71,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2917808,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6216551,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.66,5.66,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2987519,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MYS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.80,5.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Malaysia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
36676,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,33.33,33.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6578313,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,55.50,55.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9967934,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.10,1.1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
252627,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,30.27,30.27,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1940298,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4542060,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.71,5.71,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9898144,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.11,11.11,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3641007,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ROU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Romania,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8544772,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,9.18,9.18,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2257712,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.04,5.04,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4078992,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7351992,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.45,12.45,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1159793,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,14.29,14.29,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3076376,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3368091,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.29,6.29,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5087756,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.76,4.76,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5182856,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.00,3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7364693,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2499246,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,36.28,36.28,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4307466,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4408935,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,10.00,10,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7713781,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,34.15,34.15,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9452161,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.80,2.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1394641,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,20.00,20,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3292051,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ECU,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ecuador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8227795,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MMR,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Myanmar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
347852,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7009548,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BHR,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.70,1.7,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Bahrain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
544008,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.90,3.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8804456,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6184896,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3070093,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,45.11,45.11,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1711810,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,13.21,13.21,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5113181,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
290769,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6965343,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2238722,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,65.63,65.63,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5525505,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.60,0.6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8791785,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.00,6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
696354,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.38,0.38,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7434696,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.30,0.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4510422,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,42.17,42.17,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2987637,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,10.19,10.19,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6273701,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.40,0.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9756866,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.83,2.83,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8563798,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Panama,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7003244,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,23.91,23.91,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
518652,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Panama,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3837842,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2302240,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.10,11.1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Switzerland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2327728,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.00,2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8855331,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5613915,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.00,2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2569048,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,80.00,80,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4193399,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KHM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cambodia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5842322,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2778277,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SLV,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,El Salvador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1629402,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.61,3.61,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8310309,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6768864,GASP_ISOLATESDSR_PROPORTION,COUNTRY,QAT,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.60,2.6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Qatar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10157685,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5550875,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8810911,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.38,0.38,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9794811,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,9.50,9.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7815243,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KGZ,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Kyrgyzstan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2994041,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UKR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Ukraine,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4865945,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8164323,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UKR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Ukraine,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9860878,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3317481,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VEN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Venezuela (Bolivarian Republic of),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8322969,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LAO,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.56,1.56,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Lao People's Democratic Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3590289,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.60,0.6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5278042,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.80,6.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5366833,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.28,12.28,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7028713,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.87,12.87,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2327778,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.84,0.84,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
734404,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.00,8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8938085,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,69.23,69.23,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8177045,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1794395,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8570229,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,21.04,21.04,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8798233,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.26,4.26,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
715476,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.17,4.17,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7352152,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KHM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.95,3.95,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Cambodia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1001223,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2905377,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.00,5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1331282,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,66.35,66.35,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6368910,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,55.45,55.45,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1616759,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,41.46,41.46,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1692925,GASP_ISOLATESDSR_PROPORTION,COUNTRY,OMN,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Oman,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6933780,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,92.68,92.68,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Pakistan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
474245,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3768188,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MYS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,10.00,10,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Malaysia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8646084,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DOM,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,82.20,82.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Dominican Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1032904,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.85,6.85,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9319106,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,73.83,73.83,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2854612,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,10.81,10.81,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3368291,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6635559,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,83.17,83.17,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1946867,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZAF,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,South Africa,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8582991,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.76,1.76,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7009728,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,47.27,47.27,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3958534,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HRV,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Croatia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3971275,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,9.50,9.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8842789,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.13,3.13,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2664138,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,79.66,79.66,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,China,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6248503,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6534022,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8208861,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.82,1.82,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6908472,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8887267,GASP_ISOLATESDSR_PROPORTION,COUNTRY,URY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,32.00,32,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Uruguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8957206,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5779079,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZAF,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,South Africa,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9033509,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4168141,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,97.30,97.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9249440,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.10,3.1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2880059,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2956129,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,45.45,45.45,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6299117,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.11,11.11,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9674661,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UGA,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Uganda,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4828087,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,97.57,97.57,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,China,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1731014,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,39.09,39.09,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5018369,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6673697,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,19.24,19.24,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,China,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5328892,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UGA,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,53.25,53.25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Uganda,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5652214,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8919112,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.73,12.73,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4130066,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8259819,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.95,0.95,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7847184,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.00,2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9808710,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9814617,GASP_ISOLATESDSR_PROPORTION,COUNTRY,EST,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Estonia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9855486,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9917653,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.49,1.49,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9936614,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,87.78,87.78,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Brunei Darussalam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9950190,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9955895,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,82.00,82,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9981955,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10000904,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.54,0.54,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10013425,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10050484,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MOZ,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Mozambique,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10050727,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10062851,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10088406,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10145548,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10152602,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,50.70,50.7,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
50301,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,27.22,27.22,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
81627,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.23,0.23,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
203135,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,48.90,48.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
272708,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
279211,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZAF,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,South Africa,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
297341,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DOM,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,74.20,74.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Dominican Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
361132,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
417910,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,76.67,76.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
461981,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
481732,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,14.00,14,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
519082,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
621354,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.33,6.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
696651,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
716085,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
722466,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
734626,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.78,2.78,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
747556,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,44.74,44.74,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
760915,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
786363,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.30,2.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
843058,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,34.18,34.18,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
843291,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.26,3.26,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
938247,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,15.84,15.84,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
944618,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,16.06,16.06,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
963763,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,58.00,58,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
976063,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,19.13,19.13,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
982924,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.32,0.32,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1007836,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.50,4.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1027191,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DOM,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Dominican Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1046169,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MMR,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.50,12.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Myanmar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1090987,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BHR,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Bahrain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1097215,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,19.13,19.13,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1115839,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.88,5.88,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1116253,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,70.59,70.59,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Brunei Darussalam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1128359,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KHM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,92.31,92.31,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cambodia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1128958,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1141518,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1141555,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IDN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Indonesia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1148223,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FJI,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Fiji,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1160200,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.55,4.55,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1160462,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,21.15,21.15,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1167259,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SAU,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CRO,2019,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.00,5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Saudi Arabia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1217826,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1249159,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1262279,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.78,0.78,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1262612,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1281036,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1338545,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UKR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Ukraine,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1344642,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1370301,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1421234,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.82,1.82,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Switzerland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1440375,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,37.00,37,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1458444,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,25.45,25.45,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1477656,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.25,1.25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1502805,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARE,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,United Arab Emirates,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1515998,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.14,0.14,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1516008,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,41.20,41.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1522621,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,25.72,25.72,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1522646,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.07,2.07,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1528250,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CZE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.11,1.11,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Czechia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1534828,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1630588,GASP_ISOLATESDSR_PROPORTION,COUNTRY,URY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,14.30,14.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Uruguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1674461,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1718993,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1719063,GASP_ISOLATESDSR_PROPORTION,COUNTRY,RUS,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Russian Federation,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1724985,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.56,0.56,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1731606,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.47,12.47,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1744592,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KHM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Cambodia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1750202,GASP_ISOLATESDSR_PROPORTION,COUNTRY,URY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Uruguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1807676,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,10.71,10.71,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1807868,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.21,2.21,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1827390,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.82,1.82,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1832778,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,28.38,28.38,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Switzerland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1840045,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1909868,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.50,1.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1991410,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,19.05,19.05,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1998466,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FIN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Finland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2004843,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2010951,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.83,1.83,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2074059,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2081146,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FJI,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Fiji,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2099904,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,16.00,16,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2125200,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,61.00,61,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2150682,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.57,3.57,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2175814,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2019,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Brunei Darussalam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2188592,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2213884,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2233135,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2252540,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.73,2.73,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2277727,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.11,1.11,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2328505,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,15.84,15.84,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2366185,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2442607,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,56.36,56.36,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2448985,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.55,2.55,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2474842,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.50,5.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2474878,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,80.00,80,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2518857,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MYS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.80,5.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Malaysia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2556852,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Pakistan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2563354,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.14,12.14,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2582670,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.93,0.93,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2582704,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,55.45,55.45,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2594551,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.14,0.14,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2608152,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.00,3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2721909,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,18.92,18.92,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2760135,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.26,0.26,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Brunei Darussalam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2772570,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2791737,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.30,1.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2810289,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.46,4.46,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2823007,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,53.29,53.29,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2874637,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARE,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United Arab Emirates,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2899782,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,73.20,73.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2911987,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KEN,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Kenya,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2931266,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2956203,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2963253,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,35.04,35.04,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3033175,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.70,12.7,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3064252,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3083999,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,15.79,15.79,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3102235,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,55.64,55.64,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Brazil,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3115305,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SLV,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,El Salvador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3121588,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UGA,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Uganda,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3128263,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,22.73,22.73,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3159947,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,16.52,16.52,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3261245,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UKR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Ukraine,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3406811,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Brazil,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3495456,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3495822,GASP_ISOLATESDSR_PROPORTION,COUNTRY,RUS,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Russian Federation,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3495981,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GHA,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Ghana,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3502647,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,9.27,9.27,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3508276,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.67,11.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,China,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3559253,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.79,2.79,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3559655,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.02,1.02,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Brunei Darussalam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3565100,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3610416,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Panama,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3660688,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.80,1.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3667405,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.00,1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3667568,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZAF,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,South Africa,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3673630,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,39.30,39.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3679486,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MYS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.80,6.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Malaysia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3680228,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IDN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Indonesia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3685803,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.04,1.04,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3699017,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3711687,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARE,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,28.57,28.57,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United Arab Emirates,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3711996,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,44.40,44.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3712161,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.32,0.32,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3743197,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3774859,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,50.80,50.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3780989,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,93.90,93.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3800148,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.80,0.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3825735,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3838306,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3844745,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3870425,GASP_ISOLATESDSR_PROPORTION,COUNTRY,URY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Uruguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3876272,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.07,2.07,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3876778,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,96.59,96.59,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3915068,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.15,0.15,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3927458,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,69.75,69.75,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3971484,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,27.30,27.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3978466,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Panama,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3984130,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,88.80,88.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4004001,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,98.99,98.99,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4028849,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,35.96,35.96,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4029236,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4035066,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,35.48,35.48,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4061016,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4067446,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4098558,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CZE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,49.00,49,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Czechia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4105481,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZAF,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,South Africa,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4117926,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.48,6.48,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4136684,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4149708,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,10.19,10.19,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4149865,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4162471,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4162857,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,72.20,72.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4200725,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4212872,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,24.00,24,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4238744,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,14.52,14.52,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,China,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4251161,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4257637,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,21.99,21.99,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4263692,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IDN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,70.00,70,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Indonesia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4269776,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4276761,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.11,11.11,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4302286,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Pakistan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4346076,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.64,1.64,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4365374,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.66,5.66,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4371584,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4377777,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,9.52,9.52,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4397372,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,7.18,7.18,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4428301,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4447393,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4479641,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,34.18,34.18,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4485745,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.20,12.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4491998,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FIN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Finland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4618900,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4619272,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,53.00,53,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4702154,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.73,2.73,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4708054,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,58.33,58.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4714024,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,34.65,34.65,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4714779,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4720394,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,58.10,58.1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4721249,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.00,3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4733818,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,88.24,88.24,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4759086,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,23.82,23.82,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4771556,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,58.77,58.77,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4771681,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KHM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.95,3.95,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Cambodia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4796447,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Brazil,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4923845,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.91,2.91,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4929881,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.21,4.21,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4942832,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MUS,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Mauritius,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4961580,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.90,0.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4987180,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.40,2.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5057031,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.83,1.83,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5088097,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5114367,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,77.14,77.14,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5126982,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DOM,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,33.33,33.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Dominican Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5215688,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5221277,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MAR,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Morocco,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5259690,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KEN,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Kenya,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5323097,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZAF,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,South Africa,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5380001,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5380130,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5399443,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ECU,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Ecuador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5405441,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5437518,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.17,4.17,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5443767,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5443877,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5469313,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.49,0.49,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5487807,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,42.50,42.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5526156,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5538796,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5557796,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5602396,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5620576,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,55.06,55.06,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5677780,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZAF,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,South Africa,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5716371,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,29.27,29.27,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5780059,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5830348,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.09,3.09,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5862172,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,65.55,65.55,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5880915,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DOM,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Dominican Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5951258,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5957172,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IDN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,80.00,80,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Indonesia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5963363,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,73.39,73.39,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5976013,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,78.57,78.57,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5976430,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.77,1.77,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6052134,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,14.30,14.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6096310,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,63.21,63.21,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6160331,GASP_ISOLATESDSR_PROPORTION,COUNTRY,OMN,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,70.83,70.83,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Oman,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6166611,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MDG,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.86,2.86,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Madagascar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6236059,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,19.86,19.86,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6242695,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CRI,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.90,3.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Costa Rica,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6274193,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,18.89,18.89,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6287019,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.45,1.45,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6311942,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KEN,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,61.90,61.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Kenya,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6331245,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6369449,GASP_ISOLATESDSR_PROPORTION,COUNTRY,QAT,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Qatar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6388779,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,15.00,15,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6401604,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.67,4.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6407517,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6420627,GASP_ISOLATESDSR_PROPORTION,COUNTRY,EST,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Estonia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6445637,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6515123,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6515192,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MDG,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Madagascar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6515543,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FIN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.90,3.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Finland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6546976,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,74.67,74.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6547676,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6559682,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Panama,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6573233,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,7.90,7.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6617031,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.91,0.91,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6629580,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,47.54,47.54,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6630273,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FJI,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Fiji,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6667423,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6680676,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6687007,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,15.80,15.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6724545,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.82,1.82,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6744180,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.89,1.89,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6756616,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.80,0.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6782430,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6808118,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.20,0.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6826306,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6832778,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.22,2.22,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6833150,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6839356,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.33,6.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6839383,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BOL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,80.00,80,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Bolivia (Plurinational State of),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6845096,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.27,2.27,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6845235,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,53.96,53.96,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6877254,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6883614,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KHM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Cambodia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6909479,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6927808,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,32.80,32.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6928493,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6997745,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7022638,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.01,1.01,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7029716,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,96.23,96.23,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7048271,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MWI,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.59,12.59,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Malawi,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7061210,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7067909,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7086312,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KHM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cambodia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7105178,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,79.46,79.46,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7118092,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7142905,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7181468,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.91,0.91,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7181618,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7212864,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UGA,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.68,0.68,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Uganda,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7213119,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,13.81,13.81,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7257627,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.00,8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7264345,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7301930,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,66.67,66.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7321319,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.26,0.26,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Brunei Darussalam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7327631,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.50,6.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7333961,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FIN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,51.20,51.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Finland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7372255,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7403977,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.15,0.15,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7435050,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.86,0.86,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7435405,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZAF,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,South Africa,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7453952,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7466848,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7479598,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,34.50,34.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7511612,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Pakistan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7518344,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HRV,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,60.00,60,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Croatia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7530539,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,29.61,29.61,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7536607,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.59,11.59,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7537308,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7543104,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,58.33,58.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7562350,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7580865,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7663895,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VEN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Venezuela (Bolivarian Republic of),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7670117,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.92,1.92,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7670497,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.27,0.27,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7720528,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.88,6.88,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7733271,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,93.02,93.02,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7739719,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IDN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,33.33,33.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Indonesia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7740175,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7745706,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.87,12.87,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7759233,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,67.92,67.92,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7802881,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.51,8.51,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7821888,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,96.61,96.61,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7821990,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MMR,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.50,12.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Myanmar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7847279,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7847634,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7879439,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.50,8.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7886276,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7924168,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.33,0.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7937019,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7937107,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.34,1.34,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7943253,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.53,5.53,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7974466,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7994010,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,13.16,13.16,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8133190,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2019,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,14.30,14.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8133563,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,34.65,34.65,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8139517,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8158167,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.90,0.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8164899,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8184171,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.90,11.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8197154,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,China,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8228118,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,28.57,28.57,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8247783,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.88,0.88,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8267102,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.50,5.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8278949,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.25,1.25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8367849,GASP_ISOLATESDSR_PROPORTION,COUNTRY,RUS,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Russian Federation,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8368449,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,27.86,27.86,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8406338,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SLV,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,El Salvador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8412380,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8431647,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8450801,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,97.59,97.59,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8519998,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,73.33,73.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8558364,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8564449,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ECU,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,80.00,80,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ecuador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8583635,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.56,5.56,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8633910,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8684607,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.52,6.52,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8685258,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8716263,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8748275,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.82,11.82,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8748638,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8888242,GASP_ISOLATESDSR_PROPORTION,COUNTRY,TUN,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Tunisia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8906530,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8920150,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,36.36,36.36,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8963636,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.76,1.76,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9015368,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,77.00,77,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9033814,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.92,0.92,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9091198,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARE,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United Arab Emirates,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9135584,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.50,1.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9142042,GASP_ISOLATESDSR_PROPORTION,COUNTRY,RUS,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.33,2.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Russian Federation,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9142077,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,57.14,57.14,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9167171,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.40,6.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9186873,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,96.00,96,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9199283,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.22,2.22,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9237557,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,92.98,92.98,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9250075,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,9.38,9.38,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9256596,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IDN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,20.00,20,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Indonesia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9287673,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,40.54,40.54,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Switzerland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9300591,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,89.38,89.38,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9300857,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.42,6.42,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9306785,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,7.95,7.95,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9307242,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CZE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.20,5.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Czechia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9332544,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,90.69,90.69,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9338427,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.67,4.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9383102,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9402059,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,25.90,25.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9421021,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LUX,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Luxembourg,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9510325,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.83,1.83,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9554384,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MUS,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CFM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Mauritius,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9681902,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZMB,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.90,4.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Zambia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9687915,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9719310,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,99.60,99.6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,China,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9719429,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2019,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9732106,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9745356,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,20.83,20.83,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9763933,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ECU,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ecuador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9791583,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,37.37,37.37,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9802805,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9803783,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9810702,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,98.04,98.04,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9819496,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,34.60,34.6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9828980,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9843585,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,14.72,14.72,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9845090,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.14,0.14,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9850322,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NIC,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Nicaragua,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9868942,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,93.02,93.02,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Brunei Darussalam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9881564,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9882007,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SAU,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Saudi Arabia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9887298,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.91,5.91,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9888572,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.55,4.55,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9913533,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.36,6.36,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9931626,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.50,5.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9932473,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.68,0.68,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9937681,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,17.60,17.6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9982087,GASP_ISOLATESDSR_PROPORTION,COUNTRY,RUS,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Russian Federation,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9983663,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.00,1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10020668,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,21.15,21.15,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10078398,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10085051,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KHM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Cambodia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10095833,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,90.91,90.91,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10096767,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Switzerland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10097101,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10103873,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.82,1.82,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10109343,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Pakistan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10122539,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,21.33,21.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10153713,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10160428,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10166700,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
790,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,28.57,28.57,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6663,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.60,11.6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
13876,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
14099,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
14715,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MMR,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Myanmar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
26897,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
32857,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.86,0.86,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
57891,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,37.50,37.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
58292,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
71357,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IDN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,80.00,80,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Indonesia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
96023,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,47.27,47.27,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
101989,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
103872,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,21.04,21.04,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
114551,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
147958,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.44,1.44,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
148160,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UGA,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.44,2.44,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Uganda,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
167284,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
198789,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,39.75,39.75,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
223323,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,13.28,13.28,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
241514,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DOM,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Dominican Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
248677,GASP_ISOLATESDSR_PROPORTION,COUNTRY,RUS,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Russian Federation,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
319328,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
324089,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VEN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Venezuela (Bolivarian Republic of),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
325966,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,60.00,60,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
355727,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KEN,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.30,5.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Kenya,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
362077,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,58.33,58.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
395061,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,15.90,15.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
400510,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
412649,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BHR,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Bahrain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
444505,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BFA,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2019,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Burkina Faso,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
463123,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2019,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.40,3.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
470469,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,34.80,34.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
476680,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UKR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Ukraine,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
488714,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DOM,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,75.76,75.76,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Dominican Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
502920,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.83,2.83,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
508932,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.93,11.93,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
522120,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.20,2.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
539432,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.20,2.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
547165,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KHM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,50.00,50,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Cambodia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
565881,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
571693,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MWI,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Malawi,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
579016,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.13,5.13,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
590166,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
590763,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
591898,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
591937,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.10,8.1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
609125,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
611020,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,90.63,90.63,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Pakistan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
615702,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,40.91,40.91,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
622559,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,10.20,10.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
623541,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LAO,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,86.25,86.25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Lao People's Democratic Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
634648,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BOL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Bolivia (Plurinational State of),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
636341,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.17,4.17,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
641689,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
648585,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.80,0.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
648941,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,33.99,33.99,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
659863,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Pakistan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
691523,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.54,0.54,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
692972,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CZE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,21.10,21.1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Czechia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
711023,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,34.86,34.86,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
718208,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
718493,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.51,0.51,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
731457,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SAU,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,16.67,16.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Saudi Arabia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
736317,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.70,0.7,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
742571,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HRV,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2019,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Croatia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
743843,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,60.00,60,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
755572,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FIN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Finland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
761869,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UKR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ukraine,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
763128,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
769535,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.68,0.68,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
774427,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.91,0.91,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
782057,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.02,1.02,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Brunei Darussalam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
799503,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,97.97,97.97,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
800339,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.12,2.12,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
800832,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
807254,GASP_ISOLATESDSR_PROPORTION,COUNTRY,TON,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,25.00,25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Tonga,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
807364,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
812607,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
812611,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
814043,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,25.00,25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
826142,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
844513,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.80,3.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
844598,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,48.48,48.48,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
845698,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
863058,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
869674,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.42,6.42,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
877423,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.80,1.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
888518,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.52,6.52,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
902567,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,15.00,15,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
928096,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,96.00,96,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1003672,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.98,4.98,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1021750,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.57,3.57,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1022084,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.80,5.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1035081,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,63.01,63.01,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1040611,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZAF,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,South Africa,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1040640,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1041032,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1041522,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.60,5.6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1055391,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1080516,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1086921,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1099579,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,14.89,14.89,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1116990,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,96.05,96.05,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1149257,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.17,5.17,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1149747,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UGA,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,98.80,98.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Uganda,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1156721,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.56,5.56,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1156910,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1162400,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1173979,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,62.70,62.7,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1180915,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1181082,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1195053,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,65.82,65.82,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1199874,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1225279,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.82,6.82,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1252135,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,15.13,15.13,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1262865,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,21.22,21.22,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1275972,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,15.13,15.13,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1276196,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1276599,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.00,2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1289095,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.80,4.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1289228,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1300840,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.28,0.28,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1314426,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,14.00,14,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1314849,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1326142,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,46.90,46.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1326253,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.48,0.48,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1346091,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1358871,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1377754,GASP_ISOLATESDSR_PROPORTION,COUNTRY,EST,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Estonia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1384644,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1385356,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,9.09,9.09,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1390585,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.76,4.76,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Panama,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1408681,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1410412,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1415588,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.33,8.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1441357,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.50,12.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1441723,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,67.55,67.55,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1446810,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,7.94,7.94,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1474215,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.86,0.86,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1493350,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.13,3.13,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1505759,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1523900,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1524721,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.27,2.27,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1555617,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.49,0.49,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1562680,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.57,0.57,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1568610,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1569234,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1581595,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,22.73,22.73,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1594511,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,29.33,29.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1605478,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,10.91,10.91,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1605850,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.00,6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1625371,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1637005,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,46.22,46.22,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1643916,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,9.63,9.63,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1650809,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.64,3.64,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1657813,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1663104,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1681849,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.86,0.86,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1707814,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,57.27,57.27,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1720814,GASP_ISOLATESDSR_PROPORTION,COUNTRY,EST,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Estonia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1721493,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ROU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,15.38,15.38,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Romania,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1733982,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,55.79,55.79,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,China,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1738851,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.50,5.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1765629,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.26,0.26,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1784283,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,57.14,57.14,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1802185,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LUX,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,77.80,77.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Luxembourg,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1803529,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.19,5.19,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1840138,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Panama,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1867476,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1892123,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ROU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.56,2.56,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Romania,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1904836,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1911609,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1942696,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1961336,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,19.08,19.08,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1975189,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,79.17,79.17,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1992611,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IDN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Indonesia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2032190,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2032629,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UGA,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Uganda,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2038744,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2044982,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,44.64,44.64,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2082444,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DOM,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Dominican Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2088326,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2094060,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2100357,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.50,5.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2114461,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.30,1.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2126302,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,58.70,58.7,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2126823,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2133238,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2145853,GASP_ISOLATESDSR_PROPORTION,COUNTRY,EST,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Estonia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2157703,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.13,0.13,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2172259,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,36.80,36.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2178539,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,40.00,40,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2184394,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2222338,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.30,3.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2227644,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UKR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ukraine,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2235414,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.38,2.38,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2235493,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.75,0.75,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2240257,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.49,8.49,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2247726,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.89,1.89,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2252693,GASP_ISOLATESDSR_PROPORTION,COUNTRY,EST,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Estonia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2254948,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,34.78,34.78,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2259081,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,59.38,59.38,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2267311,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2272371,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ROU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,15.38,15.38,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Romania,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2272726,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.69,4.69,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2297536,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2317565,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,22.00,22,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2324220,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.60,6.6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2330039,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,97.50,97.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2361116,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,17.50,17.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2362088,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KEN,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Kenya,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2386592,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ROU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Romania,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2388391,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2393192,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2399107,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KEN,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,39.60,39.6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Kenya,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2443659,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.83,1.83,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2488541,GASP_ISOLATESDSR_PROPORTION,COUNTRY,RUS,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,53.32,53.32,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Russian Federation,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2513713,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,36.43,36.43,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2521136,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UKR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Ukraine,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2521522,GASP_ISOLATESDSR_PROPORTION,COUNTRY,EST,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Estonia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2532314,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.23,0.23,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2533503,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,90.28,90.28,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2533988,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZAF,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CFM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,South Africa,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2539256,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2565357,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.42,6.42,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2604063,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.92,1.92,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2615495,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2634796,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2646849,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2711262,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.64,1.64,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2730570,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MMR,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Myanmar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2735517,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,71.79,71.79,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Panama,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2741705,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,43.71,43.71,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2741807,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,61.54,61.54,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2742517,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2768934,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,9.43,9.43,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2779573,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.48,2.48,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2799232,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,65.22,65.22,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2818292,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DOM,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Dominican Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2818609,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.50,2.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2830428,GASP_ISOLATESDSR_PROPORTION,COUNTRY,OMN,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Oman,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2838975,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2844723,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HRV,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Croatia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2869894,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.43,2.43,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2902041,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,57.53,57.53,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2913877,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HRV,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Croatia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2914817,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.67,3.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2933160,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2933575,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.90,11.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2939658,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.00,3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2951082,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.00,11,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2952469,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.20,2.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2972117,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.64,3.64,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3014408,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.00,1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3028686,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.00,11,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3054410,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.51,3.51,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3060446,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,99.25,99.25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,China,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3065821,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VEN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Venezuela (Bolivarian Republic of),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3067083,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,66.03,66.03,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3071511,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3085145,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KEN,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Kenya,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3091779,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.40,0.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3103363,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SLV,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,El Salvador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3124224,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.91,0.91,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3130576,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3142870,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,7.69,7.69,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3180964,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.20,1.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3181239,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.90,2.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3185836,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3186441,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3205826,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,10.81,10.81,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3211589,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,61.47,61.47,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3212689,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.75,3.75,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3213262,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.03,3.03,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3218229,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.52,6.52,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3262964,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.45,5.45,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3313960,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3357843,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,65.00,65,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3396900,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3403218,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.50,1.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3403328,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.25,6.25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3421632,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,76.39,76.39,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3427397,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.80,2.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3434782,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KGZ,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Kyrgyzstan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3439466,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.91,0.91,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3446153,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.55,4.55,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3471613,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3477782,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LAO,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,86.15,86.15,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Lao People's Democratic Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3485613,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3491245,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.17,0.17,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3491937,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3497811,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3502866,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,7.25,7.25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3510978,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ECU,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,83.33,83.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Ecuador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3516022,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,7.69,7.69,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3521721,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.64,3.64,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3522031,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3529556,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,38.46,38.46,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3541875,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DOM,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Dominican Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3549237,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,74.55,74.55,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3555628,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3566188,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.80,4.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3585323,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZWE,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.30,12.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Zimbabwe,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3585491,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,44.00,44,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3631627,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MUS,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Mauritius,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3649162,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Brazil,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3650686,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.82,1.82,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3655961,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KEN,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.27,11.27,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Kenya,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3680959,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KHM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cambodia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3682480,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3713227,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,38.18,38.18,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3737955,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3745134,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3750416,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.30,1.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3770707,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3777144,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.39,1.39,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3777149,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3782802,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,34.53,34.53,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3782879,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MUS,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Mauritius,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3814267,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MDG,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Madagascar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3815929,GASP_ISOLATESDSR_PROPORTION,COUNTRY,EST,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,50.00,50,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Estonia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3834929,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3839394,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3841090,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,18.57,18.57,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3841099,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3846248,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.80,0.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3852760,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.44,2.44,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3890203,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.64,3.64,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3890715,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3903483,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.45,5.45,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3915807,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.57,3.57,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3917259,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VEN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,21.43,21.43,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Venezuela (Bolivarian Republic of),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3960391,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,53.62,53.62,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3961656,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZAF,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,South Africa,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3966063,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,45.92,45.92,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3966088,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,94.37,94.37,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Pakistan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3991669,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.91,0.91,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3998129,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4005859,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,24.60,24.6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4018369,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4024966,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,34.02,34.02,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4049530,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4050117,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,70.00,70,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4056300,GASP_ISOLATESDSR_PROPORTION,COUNTRY,EST,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Estonia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4106735,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UGA,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Uganda,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4112965,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,68.75,68.75,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4126177,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,53.90,53.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4144593,GASP_ISOLATESDSR_PROPORTION,COUNTRY,RUS,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Russian Federation,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4145061,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4158586,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.19,6.19,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4169590,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ECU,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,85.71,85.71,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Ecuador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4171098,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,13.40,13.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4171372,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,27.49,27.49,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4176934,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4182749,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.46,2.46,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4190014,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.54,11.54,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4208010,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4209313,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,56.40,56.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4232837,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ECU,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ecuador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4265938,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KEN,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Kenya,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4284458,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,9.43,9.43,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4297030,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KEN,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Kenya,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4297423,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,20.00,20,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4303186,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZAF,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,South Africa,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4303779,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.64,3.64,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4322333,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.19,5.19,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4341595,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.40,2.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4353903,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,89.15,89.15,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Brunei Darussalam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4386379,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4386420,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CRO,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.88,4.88,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Pakistan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4386470,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MWI,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Malawi,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4397534,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.99,0.99,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4405903,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4416599,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.23,0.23,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4417273,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4417817,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4418541,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MYS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,80.00,80,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Malaysia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4429409,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4442130,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,58.72,58.72,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4550195,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.70,3.7,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4581952,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4588870,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.80,4.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4615368,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,55.62,55.62,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4626423,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,63.00,63,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4626582,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.83,2.83,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4640143,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,78.00,78,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4640730,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HRV,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Croatia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4645275,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.24,2.24,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4646869,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,14.77,14.77,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4651973,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Switzerland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4653159,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.87,0.87,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4653270,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4672629,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MWI,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,92.01,92.01,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Malawi,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4690177,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4740577,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,65.52,65.52,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4747006,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.20,8.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4747429,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4773912,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SLV,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,El Salvador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4778961,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZWE,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,66.67,66.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Zimbabwe,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4780039,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KEN,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Kenya,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4793038,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,10.19,10.19,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4824307,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2019,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4830658,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.03,0.03,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4837407,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4854739,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.76,1.76,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4867217,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4867489,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,73.10,73.1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4868061,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,75.71,75.71,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4873507,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.00,4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4899837,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.30,12.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4939197,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2019,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.90,6.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4944868,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4956415,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,17.27,17.27,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4970664,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.75,8.75,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4976927,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2019,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Panama,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4994820,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,26.81,26.81,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5040166,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FIN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.30,11.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Finland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5051263,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,30.11,30.11,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5064583,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,41.74,41.74,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5064972,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,41.90,41.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5071726,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CZE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Czechia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5076820,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5116045,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,50.00,50,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5120868,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MMR,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,66.67,66.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Myanmar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5127555,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5134086,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,66.70,66.7,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5140798,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,58.72,58.72,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5153908,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,80.15,80.15,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5160197,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5184364,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.62,6.62,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5205448,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5222238,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5229665,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.92,1.92,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5229954,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UKR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Ukraine,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5230146,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,30.96,30.96,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5236275,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5260583,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5267969,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.12,0.12,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5312551,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,22.20,22.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5324759,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.15,3.15,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5336989,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.56,5.56,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Switzerland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5338441,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.06,1.06,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5349246,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5350171,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LUX,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,10.00,10,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Luxembourg,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5350952,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZWE,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Zimbabwe,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5362195,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,92.24,92.24,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5376557,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,56.36,56.36,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5389287,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5400470,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5426654,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5431897,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,28.00,28,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5432500,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.20,2.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5432647,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5438930,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5439754,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.27,2.27,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5444881,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5457410,GASP_ISOLATESDSR_PROPORTION,COUNTRY,RUS,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Russian Federation,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5458350,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5458887,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.66,0.66,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5471309,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Switzerland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5484459,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5489185,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,96.19,96.19,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5496899,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5501390,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.27,0.27,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5508685,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.46,4.46,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5508712,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.19,6.19,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5515560,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.55,4.55,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5527618,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,70.84,70.84,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5533673,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,71.56,71.56,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5546363,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.71,1.71,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5573303,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5598681,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.01,0.01,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5603931,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5609325,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.82,11.82,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5615717,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5616149,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MDG,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,93.18,93.18,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Madagascar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5621667,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,10.19,10.19,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5635196,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5655401,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,97.73,97.73,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5692596,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5705867,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.50,5.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5749288,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,43.90,43.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5756645,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,7.62,7.62,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5768174,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5788599,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.51,8.51,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5793275,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.00,1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5800229,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.30,11.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5813734,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5826643,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,93.70,93.7,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5863228,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5870671,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.50,1.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5876734,GASP_ISOLATESDSR_PROPORTION,COUNTRY,OMN,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Oman,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5902788,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HRV,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Croatia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5921808,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5927461,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5933361,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,86.11,86.11,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5934498,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5940924,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.79,2.79,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5945118,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.98,1.98,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5964996,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,35.42,35.42,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5983633,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HRV,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Croatia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5984219,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,79.85,79.85,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6003292,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.21,2.21,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6010103,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6022253,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Panama,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6022737,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,20.49,20.49,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6023123,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6034641,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,25.81,25.81,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6035330,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6048248,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SLV,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,El Salvador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6048658,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6054818,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,68.52,68.52,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6060387,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.33,8.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6072425,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.00,6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6085780,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,13.89,13.89,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6091109,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.38,2.38,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6098970,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6099146,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HRV,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Croatia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6117407,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UKR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ukraine,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6117870,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6143592,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6149527,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6173904,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6192981,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6200225,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6206112,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KHM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,66.67,66.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Cambodia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6212772,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6251783,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6269665,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.01,1.01,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6276821,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.40,3.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6281515,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,14.00,14,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6288263,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.00,2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6301319,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,26.90,26.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6301596,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6302069,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,71.00,71,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6313601,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6325918,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MDG,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.23,1.23,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Madagascar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6351154,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,63.92,63.92,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6352255,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6358280,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.48,3.48,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6364811,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARE,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.88,5.88,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United Arab Emirates,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6365684,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MOZ,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Mozambique,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6384116,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KHM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Cambodia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6409793,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6422749,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NIC,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Nicaragua,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6434959,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6446795,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6459464,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.50,6.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6473348,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.67,1.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Brazil,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6517134,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6522935,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ROU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Romania,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6529095,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6549523,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SAU,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.13,3.13,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Saudi Arabia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6554314,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.55,4.55,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6561835,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6600926,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6624839,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.83,1.83,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6625146,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,94.12,94.12,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6643360,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6644299,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.90,3.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6650774,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DOM,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Dominican Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6657940,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.45,5.45,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6669449,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6687714,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,7.41,7.41,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6689505,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,89.06,89.06,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6695222,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,57.14,57.14,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6712987,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.89,1.89,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6770097,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,27.45,27.45,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6770347,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6770695,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6783229,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6789839,GASP_ISOLATESDSR_PROPORTION,COUNTRY,EST,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Estonia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6791293,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.25,3.25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6795594,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,22.20,22.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6803978,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CZE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.90,1.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Czechia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6833911,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,62.03,62.03,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6834520,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.93,11.93,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6854374,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,66.67,66.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6885383,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6885402,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6890905,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6891871,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.11,11.11,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6936900,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Israel,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6937129,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6961286,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UGA,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Uganda,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6993678,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7012910,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7018045,GASP_ISOLATESDSR_PROPORTION,COUNTRY,TON,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Tonga,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7036600,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7037258,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7068235,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7069512,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.15,0.15,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7082497,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MWI,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,92.01,92.01,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Malawi,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7087478,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,95.83,95.83,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7088897,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.88,5.88,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7088948,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.40,1.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7093945,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,7.62,7.62,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7093970,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,49.01,49.01,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7094203,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7100433,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7106859,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,75.00,75,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7108017,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LUX,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Luxembourg,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7119434,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7119565,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,21.99,21.99,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7125859,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,35.23,35.23,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7133500,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.92,3.92,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7138497,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7156777,GASP_ISOLATESDSR_PROPORTION,COUNTRY,TUN,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Tunisia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7157354,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7163784,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ECU,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Ecuador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7169588,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.75,8.75,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7177708,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MMR,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,90.00,90,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Myanmar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7213778,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,58.72,58.72,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7214043,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7214494,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,68.18,68.18,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7234032,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.00,2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7245840,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.31,0.31,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7252746,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7258842,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.51,4.51,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7310395,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.40,6.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7311094,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,32.43,32.43,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7321923,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7328601,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,13.40,13.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7340758,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7341099,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,75.28,75.28,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7347110,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,76.05,76.05,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7348692,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7361683,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.53,5.53,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7380388,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7392045,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,86.98,86.98,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7399954,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,30.11,30.11,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7410775,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.85,3.85,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7412517,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,50.00,50,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7438189,GASP_ISOLATESDSR_PROPORTION,COUNTRY,OMN,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,54.55,54.55,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Oman,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7450666,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Pakistan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7482406,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.33,1.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7487935,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZAF,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,South Africa,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7494267,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MDG,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Madagascar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7506872,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZAF,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,South Africa,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7545419,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,13.79,13.79,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7550340,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.20,1.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7557948,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7582571,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,46.67,46.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7584108,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Panama,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7608467,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,92.16,92.16,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7614964,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7621897,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,67.89,67.89,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7628427,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.13,3.13,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7665217,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7715314,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.28,1.28,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7716269,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.71,1.71,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7728321,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.06,0.06,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7728554,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.05,12.05,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,China,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7729673,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VEN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Venezuela (Bolivarian Republic of),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7735697,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KEN,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Kenya,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7740813,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.25,3.25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7741770,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Pakistan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7742140,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,30.67,30.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7791117,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MDG,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.63,2.63,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Madagascar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7791652,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7824702,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,93.75,93.75,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7824771,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7837071,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7843742,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.36,5.36,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7856432,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7874222,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.08,8.08,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7893121,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.82,6.82,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7900376,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7900541,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,20.35,20.35,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7905509,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.82,1.82,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7919257,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7920169,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7937253,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.40,0.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7963512,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7976985,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.28,12.28,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7977091,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.45,1.45,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8008168,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.30,0.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8026800,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Israel,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8026836,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,20.00,20,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8027117,GASP_ISOLATESDSR_PROPORTION,COUNTRY,RUS,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,16.98,16.98,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Russian Federation,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8102215,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.78,12.78,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,China,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8102263,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,18.18,18.18,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8129439,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.80,1.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8134774,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.06,1.06,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8141517,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8186447,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SAU,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Saudi Arabia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8205300,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.48,0.48,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8211683,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8216678,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,65.05,65.05,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8223755,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8224248,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.04,0.04,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8237227,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.51,0.51,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Brunei Darussalam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8243247,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.94,0.94,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8248535,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,17.80,17.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8256711,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,25.89,25.89,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8269071,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,7.34,7.34,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8274826,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.23,6.23,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8286362,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,19.20,19.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8286673,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8319319,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IDN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,16.67,16.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Indonesia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8324597,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8325692,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8344944,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,45.57,45.57,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8356354,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MWI,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,73.85,73.85,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Malawi,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8376563,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.00,1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8394628,GASP_ISOLATESDSR_PROPORTION,COUNTRY,URY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Uruguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8395835,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,95.12,95.12,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Pakistan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8407721,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8427125,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8440449,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,33.33,33.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8440471,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.38,2.38,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8444939,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8451011,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,69.05,69.05,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8451372,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8463732,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UGA,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,95.40,95.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Uganda,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8470608,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ECU,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Ecuador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8471130,GASP_ISOLATESDSR_PROPORTION,COUNTRY,EST,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Estonia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8484682,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.88,4.88,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Pakistan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8497021,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DOM,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Dominican Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8509422,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Panama,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8510182,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.67,3.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8516135,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.63,2.63,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8533600,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LUX,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Luxembourg,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8540345,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,7.70,7.7,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8540864,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8540961,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UKR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Ukraine,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8547052,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.50,6.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8548233,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HRV,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Croatia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8567117,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.50,1.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8578641,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,49.49,49.49,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8604349,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MYS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Malaysia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8615974,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8635910,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SLV,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,El Salvador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8667790,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HRV,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,37.50,37.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Croatia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8680404,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.73,2.73,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8681030,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BOL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,40.00,40,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Bolivia (Plurinational State of),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8685387,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8686456,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8692958,GASP_ISOLATESDSR_PROPORTION,COUNTRY,RUS,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,16.55,16.55,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Russian Federation,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8699496,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,55.60,55.6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8705104,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.90,0.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8705960,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.00,1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8706094,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.29,0.29,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8717275,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8731484,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.33,6.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8737276,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8737416,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MYS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,64.24,64.24,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Malaysia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8743683,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8774618,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8780401,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,22.50,22.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8806107,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ECU,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,20.00,20,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ecuador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8812804,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8813049,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.52,6.52,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8818658,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LUX,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Luxembourg,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8819566,GASP_ISOLATESDSR_PROPORTION,COUNTRY,EST,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Estonia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8825085,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SAU,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,16.67,16.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Saudi Arabia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8844260,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8852186,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.51,0.51,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Brunei Darussalam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8883585,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.56,2.56,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8903197,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,19.82,19.82,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8914470,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,7.81,7.81,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8914764,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8920815,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8920957,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UGA,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.66,0.66,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Uganda,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8945866,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,26.09,26.09,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8952729,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8965387,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,14.80,14.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8971959,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LUX,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Luxembourg,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8973217,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,29.17,29.17,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8978404,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,7.14,7.14,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8997469,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,15.24,15.24,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9010592,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,15.20,15.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,China,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9022350,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FJI,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.96,1.96,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Fiji,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9029305,GASP_ISOLATESDSR_PROPORTION,COUNTRY,TZA,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,18.18,18.18,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,United Republic of Tanzania,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9105733,GASP_ISOLATESDSR_PROPORTION,COUNTRY,TON,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,25.00,25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Tonga,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9110745,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Pakistan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9125625,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.13,3.13,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9130725,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9157422,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.40,0.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9163586,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9193710,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,35.00,35,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9213635,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.36,6.36,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9226125,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ROU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,77.78,77.78,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Romania,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9239980,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,37.62,37.62,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9258039,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,80.00,80,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9269647,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.20,8.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9269956,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.91,6.91,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Brazil,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9314151,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,61.82,61.82,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9315625,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9346148,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.91,0.91,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9358365,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.57,3.57,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9378050,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,42.55,42.55,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9398272,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,83.82,83.82,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Brunei Darussalam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9429617,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Pakistan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9430281,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UKR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Ukraine,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9435618,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.76,4.76,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9474710,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9487264,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9497993,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.04,0.04,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9499330,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,96.09,96.09,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9506040,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9506171,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,96.10,96.1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9517713,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9518206,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LUX,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,70.00,70,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Luxembourg,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9549285,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KGZ,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Kyrgyzstan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9557251,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9574750,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9606474,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,95.00,95,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9619900,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SLV,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,20.00,20,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,El Salvador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9620644,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9626955,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.37,1.37,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9639667,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9702115,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9715729,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,25.00,25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9746498,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,40.43,40.43,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9765671,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.37,4.37,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9802872,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9811516,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HRV,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.11,11.11,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Croatia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9813591,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.00,4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9821771,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DOM,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Dominican Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9830244,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DOM,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Dominican Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9858367,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.43,0.43,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9858674,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9860243,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ECU,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ecuador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9902183,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UGA,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.09,0.09,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Uganda,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9922884,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MOZ,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Mozambique,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9934952,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9935076,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.46,2.46,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9940596,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,26.21,26.21,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9965274,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9971650,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,91.80,91.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9978100,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.45,5.45,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9979665,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,45.12,45.12,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9984867,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CZE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Czechia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10004244,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.93,0.93,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10022446,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10028617,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10030175,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.40,0.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10035528,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10035922,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,92.70,92.7,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10042270,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Pakistan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10055097,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.54,0.54,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10067946,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10068135,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,42.30,42.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10104809,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10118707,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10132056,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.30,1.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10136612,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HRV,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,80.00,80,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Croatia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10143230,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10149921,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
10169309,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FIN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Finland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
21846,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
35223,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
53103,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
78534,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,98.36,98.36,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
79391,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
104423,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
116665,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
155391,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.70,0.7,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Switzerland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
162165,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
168467,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
180783,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.42,0.42,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
213013,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
237276,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,43.27,43.27,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
244582,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,23.91,23.91,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
257017,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
258247,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.78,0.78,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
270783,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
301208,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
302017,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,China,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
303103,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
321296,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,27.50,27.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
322152,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.28,0.28,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
339324,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
359214,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
365890,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.89,0.89,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
366322,GASP_ISOLATESDSR_PROPORTION,COUNTRY,EST,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Estonia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
370458,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,58.18,58.18,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
370881,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,50.00,50,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
376696,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,42.10,42.1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
382911,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.70,3.7,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
383833,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.09,3.09,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
408774,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,76.00,76,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
409881,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MMR,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,66.67,66.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Myanmar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
410543,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,34.55,34.55,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
415597,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,97.01,97.01,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
415630,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UKR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,21.40,21.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ukraine,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
415990,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
435759,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
446121,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.12,1.12,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
446625,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,14.29,14.29,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
460966,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,7.34,7.34,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
471398,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,46.36,46.36,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
473485,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.28,1.28,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
484847,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.13,2.13,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
499115,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,46.80,46.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
510836,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.30,3.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
516942,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,49.46,49.46,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
530682,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,14.55,14.55,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
534857,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
536553,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MMR,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Myanmar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
542248,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,71.30,71.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
554882,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
556125,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,42.00,42,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
567047,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.73,4.73,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
574584,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,45.00,45,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
579822,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
581195,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.60,11.6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
594071,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.19,4.19,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
600005,GASP_ISOLATESDSR_PROPORTION,COUNTRY,EST,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Estonia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
604856,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
606920,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,22.73,22.73,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
617606,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
619647,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,67.27,67.27,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
643312,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
644434,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.34,4.34,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
649870,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
651545,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UGA,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.66,0.66,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Uganda,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
695833,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MDG,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2019,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.80,2.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Madagascar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
713255,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,33.02,33.02,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
714089,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KEN,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Kenya,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
726010,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,89.00,89,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
746028,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
771566,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,9.09,9.09,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
771689,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.83,0.83,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
845914,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.10,1.1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
846124,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MYS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,10.00,10,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Malaysia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
853293,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.33,1.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
853404,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.60,2.6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
865421,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
872097,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,74.00,74,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
872891,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,32.50,32.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
885934,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,81.96,81.96,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
904170,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,10.70,10.7,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
904648,GASP_ISOLATESDSR_PROPORTION,COUNTRY,EST,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,27.78,27.78,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Estonia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
910255,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LAO,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Lao People's Democratic Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
911732,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
917066,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.83,1.83,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
929655,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,63.30,63.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
936430,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,86.25,86.25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
948848,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,87.45,87.45,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
955347,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LAO,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Lao People's Democratic Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
968739,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.27,0.27,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
973678,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.39,0.39,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
979653,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.89,0.89,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
980777,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,69.12,69.12,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
987626,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.83,0.83,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
992844,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1006519,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1013421,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1018421,GASP_ISOLATESDSR_PROPORTION,COUNTRY,RUS,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Russian Federation,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1031803,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DOM,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Dominican Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1032062,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Papua New Guinea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1044090,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZWE,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Zimbabwe,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1044597,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.36,6.36,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1049386,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1049727,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.07,1.07,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1056003,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1069742,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,56.60,56.6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1113234,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GTM,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Guatemala,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1126702,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.91,1.91,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1165386,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LAO,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.56,1.56,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Lao People's Democratic Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1210223,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,9.10,9.1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1214457,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,18.75,18.75,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Switzerland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1265144,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARE,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United Arab Emirates,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1286052,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1297437,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,97.35,97.35,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1336168,GASP_ISOLATESDSR_PROPORTION,COUNTRY,EST,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,42.90,42.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Estonia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1343105,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HRV,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Croatia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1356024,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1362545,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.56,5.56,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1367269,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARE,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,77.61,77.61,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United Arab Emirates,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1379836,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2019,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.60,3.6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Brunei Darussalam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1379991,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1406249,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.08,8.08,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1425364,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MMR,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Myanmar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1426067,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1449600,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1463329,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1469174,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.19,6.19,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1474809,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,14.77,14.77,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1476207,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,31.00,31,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1495706,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,50.00,50,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1520521,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1526067,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1552189,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1557857,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1559109,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.92,3.92,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1576872,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.64,3.64,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1601122,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.25,1.25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1601317,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VEN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Venezuela (Bolivarian Republic of),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1602419,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1620274,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1626821,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,16.00,16,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1635287,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,93.18,93.18,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Brunei Darussalam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1653262,GASP_ISOLATESDSR_PROPORTION,COUNTRY,OMN,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Oman,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1684172,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LUX,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Luxembourg,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1690684,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,29.27,29.27,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1692328,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1698782,GASP_ISOLATESDSR_PROPORTION,COUNTRY,RUS,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Russian Federation,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1709310,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1717082,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.42,6.42,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1723402,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1778998,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,7.90,7.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1779484,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1779892,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1800037,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARE,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.80,1.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,United Arab Emirates,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1805006,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,13.82,13.82,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1817418,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Panama,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1817991,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.04,4.04,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1823847,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SLV,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,El Salvador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1830625,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,14.29,14.29,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1843896,GASP_ISOLATESDSR_PROPORTION,COUNTRY,EST,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Estonia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1882599,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1887993,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.78,2.78,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1888473,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,46.46,46.46,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1889327,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.82,1.82,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1894104,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,25.00,25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1901255,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1906182,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1908300,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.17,4.17,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1919252,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1925959,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IDN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Indonesia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1931901,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SLV,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,El Salvador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1958103,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1958379,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1964904,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.77,3.77,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
1989536,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,14.60,14.6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,China,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2033795,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.88,1.88,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2064639,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UKR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,10.00,10,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ukraine,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2078146,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.25,1.25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2085710,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,34.15,34.15,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2104566,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,73.68,73.68,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2147236,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.44,0.44,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2155421,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2160008,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZMB,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Zambia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2167631,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2179879,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2185643,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.20,2.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2199909,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,74.38,74.38,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2223325,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.26,3.26,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2224456,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2249917,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2262770,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2281271,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.93,0.93,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2281310,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FIN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Finland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2289177,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.46,0.46,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2312490,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.70,8.7,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2339652,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.10,6.1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2369826,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,19.08,19.08,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2382137,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,98.36,98.36,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2382837,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IDN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,33.33,33.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Indonesia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2390480,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2408908,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2414782,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MAR,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Morocco,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2415189,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.00,6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2496880,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,27.57,27.57,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2516686,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,58.10,58.1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2521968,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SLV,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,El Salvador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2522391,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.09,8.09,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2522962,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2534585,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.56,1.56,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2536533,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZAF,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,South Africa,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2542507,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,7.69,7.69,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2568246,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,25.45,25.45,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2586057,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KEN,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,53.25,53.25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Kenya,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2606571,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UGA,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Uganda,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2616865,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2623478,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2625240,GASP_ISOLATESDSR_PROPORTION,COUNTRY,URY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Uruguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2629472,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CZE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.11,1.11,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Czechia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2630516,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ECU,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ecuador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2631040,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.15,3.15,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2656889,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,25.00,25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2662199,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.25,1.25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2674018,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,91.37,91.37,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2687719,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,25.00,25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2701355,GASP_ISOLATESDSR_PROPORTION,COUNTRY,RUS,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Russian Federation,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2706669,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2714235,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,61.20,61.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2719352,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2719734,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2732355,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2745339,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,51.50,51.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2758191,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.52,6.52,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2775801,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2776436,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KHM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Cambodia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2783039,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IDN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Indonesia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2796141,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2827775,GASP_ISOLATESDSR_PROPORTION,COUNTRY,RUS,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,32.62,32.62,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Russian Federation,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2828192,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.56,2.56,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2828448,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,62.41,62.41,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2833488,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FJI,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Fiji,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2853748,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2877569,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.83,0.83,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Brazil,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2877888,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.90,1.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2891071,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,60.00,60,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2891959,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2898279,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,83.75,83.75,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2904567,GASP_ISOLATESDSR_PROPORTION,COUNTRY,EST,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,15.38,15.38,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Estonia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2909192,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,40.47,40.47,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2916146,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,25.00,25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2922804,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,18.02,18.02,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2923330,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2929260,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,36.00,36,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2934823,GASP_ISOLATESDSR_PROPORTION,COUNTRY,URY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,9.09,9.09,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Uruguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2942622,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KHM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Cambodia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2987245,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2991832,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,46.22,46.22,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2992926,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.53,5.53,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
2999139,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SAU,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Saudi Arabia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3004063,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,22.90,22.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3010301,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3011333,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,32.16,32.16,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3050048,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3056714,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARE,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United Arab Emirates,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3093220,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,33.30,33.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Panama,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3094519,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,30.60,30.6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3101198,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,63.37,63.37,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3106436,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3112106,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3124877,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.20,11.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3144068,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.21,4.21,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3145306,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3149909,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.00,2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3151874,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.00,2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3176113,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.00,6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3188978,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,15.40,15.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3189160,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3201939,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FJI,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Fiji,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3207095,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.73,2.73,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3207526,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,71.43,71.43,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3209198,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3209278,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3220378,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MDG,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.50,2.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Madagascar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3220672,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3220680,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,7.07,7.07,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3226515,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3232232,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.91,1.91,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3232303,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3232459,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,65.27,65.27,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3245021,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UGA,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.68,0.68,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Uganda,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3246168,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,98.88,98.88,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3246693,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.99,0.99,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3252385,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,94.05,94.05,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3310688,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.33,3.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3316550,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CZE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.10,1.1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Czechia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3321074,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3335202,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.00,5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3365549,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3411133,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ECU,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ecuador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3417707,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.55,4.55,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3423015,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,31.98,31.98,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3423109,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3424460,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3430633,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,28.57,28.57,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3442319,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VEN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,42.86,42.86,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Venezuela (Bolivarian Republic of),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3460905,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3473566,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,77.04,77.04,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3474568,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3500921,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,14.70,14.7,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3517746,GASP_ISOLATESDSR_PROPORTION,COUNTRY,RUS,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,25.47,25.47,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Russian Federation,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3556778,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,34.25,34.25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3564012,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2019,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.90,12.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3568978,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,53.85,53.85,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3570067,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.05,12.05,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,China,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3582088,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MDG,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.23,1.23,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Madagascar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3593838,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KHM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Cambodia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3595128,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,30.67,30.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3601671,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.69,4.69,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Pakistan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3601982,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MDG,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Madagascar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3653073,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.50,6.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3665286,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3671091,GASP_ISOLATESDSR_PROPORTION,COUNTRY,EST,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2019,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,25.00,25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Estonia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3702942,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,95.12,95.12,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3710530,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.06,1.06,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3710626,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,15.24,15.24,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3727244,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,94.78,94.78,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3729099,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ROU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Romania,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3735309,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DOM,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.80,8.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Dominican Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3735790,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3742227,GASP_ISOLATESDSR_PROPORTION,COUNTRY,URY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Uruguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3747051,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.33,3.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3747377,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.80,3.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3754099,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.19,6.19,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3754227,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZAF,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,South Africa,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3754437,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3765652,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KHM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cambodia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3778253,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MYS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.35,2.35,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Malaysia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3779032,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,14.75,14.75,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3779588,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.54,0.54,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3797965,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3799005,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,55.60,55.6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3830187,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,60.00,60,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3856216,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3860975,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3886035,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3887010,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,13.50,13.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3887278,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HRV,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,66.67,66.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Croatia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3894259,GASP_ISOLATESDSR_PROPORTION,COUNTRY,RUS,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,44.42,44.42,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Russian Federation,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3899478,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,14.00,14,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3925069,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Panama,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3937288,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3937691,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3943451,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Brazil,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3945059,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3949723,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3970428,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3975106,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.12,0.12,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
3995612,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZAF,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,64.32,64.32,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,South Africa,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4006954,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4014046,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4014056,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,56.60,56.6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4015111,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4020235,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4026781,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CZE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Czechia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4033124,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,73.30,73.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4039789,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,65.73,65.73,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4046788,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4052461,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.26,4.26,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4057886,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4059109,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,70.80,70.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4059389,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4065302,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4095340,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.40,0.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4123060,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.75,0.75,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4127337,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,61.41,61.41,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4133920,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,37.27,37.27,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4152910,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.59,0.59,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4173499,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4178891,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.00,3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4211723,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4223929,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.92,0.92,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4224315,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4229613,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KGZ,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Kyrgyzstan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4242042,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.45,5.45,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4248672,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4249292,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,86.10,86.1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4261916,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LUX,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.60,5.6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Luxembourg,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4273183,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4273200,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.80,1.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4275412,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4293765,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,17.20,17.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4294226,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.88,6.88,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4299814,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4306299,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4306767,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.17,3.17,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4313095,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4317495,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,93.93,93.93,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4317767,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4331674,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZAF,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,South Africa,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4331888,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.87,0.87,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4338015,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HRV,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Croatia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4350380,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,15.80,15.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4355663,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,18.27,18.27,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4356819,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.07,0.07,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4357484,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.05,4.05,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4368707,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UGA,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Uganda,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4394070,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MMR,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Myanmar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4400414,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.68,0.68,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4407249,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4413639,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.42,0.42,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4420282,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KGZ,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Kyrgyzstan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4425677,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SAU,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Saudi Arabia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4433435,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,20.00,20,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4433761,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4458923,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4483150,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,29.55,29.55,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4489687,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.17,5.17,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4491000,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4495889,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MMR,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Myanmar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4514651,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DOM,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,56.25,56.25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Dominican Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4515049,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.50,0.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4528713,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UGA,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,82.93,82.93,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Uganda,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4528999,GASP_ISOLATESDSR_PROPORTION,COUNTRY,EST,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Estonia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4533223,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,29.41,29.41,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4584752,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARE,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United Arab Emirates,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4585267,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KEN,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,77.78,77.78,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Kenya,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4590347,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,85.71,85.71,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4592710,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.04,4.04,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4596983,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.90,2.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4597099,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,60.61,60.61,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4610126,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4616133,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4641685,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.63,2.63,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4655307,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4680158,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,22.00,22,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4681293,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.00,5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4718109,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,32.08,32.08,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4718872,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4726030,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.47,0.47,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4731426,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4755646,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MYS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.35,2.35,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Malaysia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4768994,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KEN,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Kenya,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4770402,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4781900,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,9.90,9.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4793682,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HRV,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Croatia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4794936,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,7.34,7.34,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4801247,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.83,2.83,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4808283,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,83.13,83.13,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4812919,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Brazil,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4825949,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4832185,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4857681,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CRI,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Costa Rica,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4883789,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.11,4.11,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4897096,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.90,2.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4901617,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4928902,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.27,2.27,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4946964,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SAU,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Saudi Arabia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4952195,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FIN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Finland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4984700,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LUX,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,10.00,10,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Luxembourg,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4984939,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4986075,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.22,1.22,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4990825,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VEN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Venezuela (Bolivarian Republic of),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4992360,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.43,0.43,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
4998454,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.05,0.05,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5034700,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,14.67,14.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5042398,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5047750,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.78,2.78,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5047995,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,98.67,98.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5048829,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DOM,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Dominican Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5060873,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5068384,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5072751,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.30,3.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5085386,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MYS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,74.88,74.88,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Malaysia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5086819,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FJI,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Fiji,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5091393,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.91,0.91,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5097838,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LUX,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Luxembourg,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5098760,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZAF,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,South Africa,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5105677,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5112824,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,30.91,30.91,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5118357,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,81.56,81.56,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5129913,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,15.96,15.96,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5136701,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5142559,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5162831,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BHR,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Bahrain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5173779,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5186727,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.91,0.91,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5187943,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,82.76,82.76,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5188839,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,88.89,88.89,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5193905,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5194249,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,40.00,40,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5199886,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5214231,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BOL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Bolivia (Plurinational State of),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5218488,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZAF,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,71.22,71.22,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,South Africa,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5224844,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.30,0.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5226521,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.56,1.56,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5231175,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,28.85,28.85,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5244577,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5257410,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.60,5.6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5258530,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.00,12,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5275328,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CRO,2019,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Pakistan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5287824,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.91,0.91,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5288340,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,93.65,93.65,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5288594,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5294392,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,55.00,55,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5295867,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.00,2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5327684,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.96,3.96,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5327749,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5328026,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5332393,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,47.54,47.54,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5334550,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5347020,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,7.60,7.6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5377493,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5379023,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5389610,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CZE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.10,1.1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Czechia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5409896,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5416907,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5440233,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLZ,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.50,12.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Belize,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5442468,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5466592,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.00,1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5493276,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5505302,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,15.00,15,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5512394,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZAF,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,South Africa,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5524461,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FJI,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.60,0.6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Fiji,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5529762,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,9.00,9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5536918,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.18,8.18,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5537363,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.14,1.14,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5542780,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5555681,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,15.13,15.13,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5561039,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.21,0.21,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5562547,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.15,0.15,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5562975,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LAO,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Lao People's Democratic Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5581850,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,65.57,65.57,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5594034,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,73.64,73.64,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5606094,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.40,8.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5607132,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,60.33,60.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5612009,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,50.91,50.91,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5612801,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.10,0.1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5625182,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,67.27,67.27,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5637429,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,14.20,14.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5643383,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UGA,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Uganda,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5643750,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UKR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ukraine,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5661871,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5669229,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.58,2.58,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5669638,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5688213,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DOM,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Dominican Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5694110,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,59.00,59,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5694802,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.20,4.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5700219,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,72.45,72.45,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5700321,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CZE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.90,1.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Czechia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5701336,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,29.32,29.32,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5714170,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.12,1.12,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5714573,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Brazil,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5726416,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.13,1.13,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5726452,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SLV,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,El Salvador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5744364,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.99,4.99,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5744658,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.57,8.57,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5751924,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,21.22,21.22,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5769883,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.76,4.76,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5783944,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FIN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Finland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5784125,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.04,1.04,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5797570,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.80,3.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5809816,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.87,1.87,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5815131,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.57,0.57,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5816496,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,17.27,17.27,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5822792,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.26,12.26,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5827158,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZWE,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.30,12.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Zimbabwe,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5829098,GASP_ISOLATESDSR_PROPORTION,COUNTRY,EST,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2019,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Estonia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5841430,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5841760,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.82,11.82,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5847173,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,20.87,20.87,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5865982,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.90,12.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5867247,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZAF,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,South Africa,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5873280,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,60.00,60,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5884487,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5898950,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5904485,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SLV,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,El Salvador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5936216,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5954778,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.26,5.26,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5954912,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MDG,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.50,2.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Madagascar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5955277,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,21.35,21.35,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,China,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
5967657,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.78,2.78,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6023837,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6037779,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6042805,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6044091,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.00,4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6044580,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,35.10,35.1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6063287,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6070112,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,77.07,77.07,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6080538,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6081150,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,50.93,50.93,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6088606,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,55.79,55.79,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,China,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6093463,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.78,12.78,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,China,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6094222,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.90,3.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6099705,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.40,1.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6112395,GASP_ISOLATESDSR_PROPORTION,COUNTRY,RUS,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Russian Federation,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6125644,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,70.80,70.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6132653,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,46.90,46.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6132985,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Pakistan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6139587,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6158322,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,60.10,60.1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6201822,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6209844,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,17.50,17.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6247221,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,96.14,96.14,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6285309,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6285607,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6290484,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LUX,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.60,5.6,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Luxembourg,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6297198,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,90.91,90.91,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6298310,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CZE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,52.22,52.22,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Czechia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6304439,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,60.00,60,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6304495,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DOM,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Dominican Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6317495,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UKR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Ukraine,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6322381,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,53.13,53.13,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6341282,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.33,1.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6366490,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.40,0.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6374097,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,25.00,25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6412170,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,47.00,47,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6431344,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FJI,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.18,0.18,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Fiji,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6435825,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6450956,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UKR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ukraine,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6461569,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,76.90,76.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6469543,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6493760,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.64,0.64,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6499900,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6512349,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6552461,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.96,1.96,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6558817,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,71.88,71.88,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6565062,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,75.61,75.61,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6570918,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,19.86,19.86,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6576408,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.33,1.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6582166,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.42,0.42,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6596972,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MAR,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Morocco,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6609133,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HRV,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,83.30,83.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Croatia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6626573,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6646004,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.80,1.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6646768,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6652040,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6659446,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6672589,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VEN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Venezuela (Bolivarian Republic of),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6677407,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.09,6.09,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6689719,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.09,6.09,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6703349,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.64,3.64,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6708877,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6728162,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6730134,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6734215,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,95.65,95.65,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6736037,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,13.21,13.21,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6748951,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KHM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.00,8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Cambodia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6754934,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.36,6.36,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6767454,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6768248,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.00,5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6787288,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.71,5.71,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6792340,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,60.98,60.98,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6798464,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,76.81,76.81,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6799577,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6816858,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.23,0.23,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6823129,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.64,3.64,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Brunei Darussalam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6830224,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.03,3.03,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6841998,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6844095,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.63,2.63,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6849136,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.33,1.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6849272,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6869359,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.63,0.63,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6869670,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6875071,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6911922,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6938053,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,7.07,7.07,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6938717,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IDN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,16.67,16.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Indonesia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6943521,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6952075,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6956888,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,35.00,35,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6983150,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6990101,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UKR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Ukraine,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6994178,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.06,0.06,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
6994335,GASP_ISOLATESDSR_PROPORTION,COUNTRY,URY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Uruguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7039766,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.33,8.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7039907,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,36.94,36.94,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,China,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7047123,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7052299,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7053204,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,47.34,47.34,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7059182,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7077357,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7078524,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.03,0.03,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7096299,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.50,1.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7097607,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UKR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ukraine,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7122921,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,75.50,75.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7123087,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HRV,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,33.30,33.3,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Croatia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7123243,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CYP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Cyprus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7190688,GASP_ISOLATESDSR_PROPORTION,COUNTRY,EST,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Estonia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7198378,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,44.95,44.95,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7217621,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7223672,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,80.00,80,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7237308,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,56.25,56.25,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7249652,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7256147,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7261419,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,31.22,31.22,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7266797,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.03,3.03,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7275053,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LUX,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Luxembourg,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7281258,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,74.29,74.29,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7281653,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7307282,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7324844,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.50,5.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7324899,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,86.84,86.84,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7332314,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7338736,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,60.40,60.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7343421,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,16.22,16.22,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7344995,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7345231,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,16.67,16.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7349792,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7356050,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,11.59,11.59,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7357334,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VEN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Venezuela (Bolivarian Republic of),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7357540,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.33,0.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7357965,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,99.41,99.41,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,China,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7383363,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.46,0.46,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7400621,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FJI,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.37,0.37,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Fiji,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7407098,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,79.81,79.81,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7414704,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ROU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,7.69,7.69,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Romania,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7420709,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.27,0.27,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7433479,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.90,2.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7433808,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,56.07,56.07,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7457352,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,47.86,47.86,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7459704,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HRV,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Croatia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7463576,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,53.70,53.7,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7464562,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CRO,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Pakistan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7464841,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7491068,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7491226,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7529484,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,49.12,49.12,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7546573,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ECU,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Ecuador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7573486,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MYS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,88.24,88.24,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Malaysia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7578008,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,20.87,20.87,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7584329,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,38.88,38.88,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7648103,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BOL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,80.00,80,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Bolivia (Plurinational State of),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7648659,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,36.28,36.28,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7661217,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7680626,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HRV,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Croatia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7680992,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7699039,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BOL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Bolivia (Plurinational State of),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7732229,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,96.09,96.09,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7755474,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZWE,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.80,5.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Zimbabwe,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7755769,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SAU,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,16.67,16.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Saudi Arabia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7763590,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7763946,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.40,1.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7775923,GASP_ISOLATESDSR_PROPORTION,COUNTRY,URY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Uruguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7794234,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,7.69,7.69,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7794602,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.20,1.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7807432,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7808451,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7814026,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,14.40,14.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7819404,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MDG,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2019,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.90,1.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Madagascar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7839997,GASP_ISOLATESDSR_PROPORTION,COUNTRY,TUN,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,92.31,92.31,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Tunisia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7863809,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.26,8.26,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7871711,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,93.75,93.75,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Pakistan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7871865,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,61.16,61.16,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7883925,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7889368,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7901649,GASP_ISOLATESDSR_PROPORTION,COUNTRY,EST,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Estonia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7909977,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.00,2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7915715,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.82,1.82,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7916113,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7921474,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MAR,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Morocco,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7928441,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BRA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Brazil,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7953239,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,86.11,86.11,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7965619,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.83,5.83,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7972796,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LUX,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Luxembourg,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7979030,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,40.97,40.97,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7979778,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.50,4.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7985481,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7996325,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7996725,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZAF,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,South Africa,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
7998593,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Papua New Guinea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8016967,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,72.00,72,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8022161,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,64.29,64.29,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8029120,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,55.10,55.1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8029496,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8029822,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8036852,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,96.88,96.88,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8042494,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PHL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Philippines,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8098459,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.17,4.17,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8112592,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BTN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Bhutan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8125061,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8136592,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,96.70,96.7,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8157272,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8168603,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8182348,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARE,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United Arab Emirates,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8207181,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8213086,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8258720,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,40.43,40.43,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8276622,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,57.14,57.14,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8289628,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KHM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Cambodia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8314766,GASP_ISOLATESDSR_PROPORTION,COUNTRY,RUS,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,4.91,4.91,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Russian Federation,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8315827,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.92,0.92,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8322523,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,45.40,45.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8352841,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8353940,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.07,0.07,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8364522,GASP_ISOLATESDSR_PROPORTION,COUNTRY,VNM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,93.18,93.18,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Viet Nam,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8371366,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,83.67,83.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8389927,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FIN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,42.00,42,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Finland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8391866,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,27.45,27.45,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8415154,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,57.86,57.86,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8421822,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SAU,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,93.06,93.06,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Saudi Arabia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8427889,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,99.06,99.06,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8440534,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ZAF,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,South Africa,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8442131,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,57.00,57,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8447253,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CUB,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,46.67,46.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Cuba,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8455367,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.14,12.14,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8466271,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FJI,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Fiji,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8499216,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,26.32,26.32,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8499717,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8518595,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8518706,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8537568,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.00,2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8542092,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BHR,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,86.67,86.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Bahrain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8560937,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ROU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,80.77,80.77,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Romania,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8562077,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,45.95,45.95,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8568246,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.36,6.36,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8568247,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SAU,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,90.41,90.41,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Saudi Arabia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8637714,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,20.83,20.83,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8638040,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.22,1.22,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8638184,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CZE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Czechia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8643579,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UKR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ukraine,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8657468,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8675113,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8675503,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,30.77,30.77,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8675630,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,52.48,52.48,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8676641,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IDN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,10.00,10,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Indonesia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8689026,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,46.40,46.4,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8701412,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,28.52,28.52,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8719533,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.85,3.85,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8732498,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.14,0.14,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8740136,GASP_ISOLATESDSR_PROPORTION,COUNTRY,EST,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Estonia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8745365,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.75,3.75,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8795624,GASP_ISOLATESDSR_PROPORTION,COUNTRY,OMN,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Oman,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8795942,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.83,2.83,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8827689,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8829533,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,83.33,83.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8834545,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CIV,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.00,2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Cote d'Ivoire,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8835582,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8840728,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UGA,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Uganda,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8846296,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FRA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,France,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8846474,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SGP,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Singapore,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8852907,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,73.58,73.58,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8854011,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,10.00,10,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Austria,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8866271,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DNK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Denmark,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8872724,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8879674,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.51,8.51,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Pakistan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8891302,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.55,12.55,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8917527,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,9.10,9.1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8917616,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BLR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.50,2.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Belarus,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8922579,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DOM,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Dominican Republic,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8955078,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ARG,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.50,0.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Argentina,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8967764,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FJI,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.37,0.37,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Fiji,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8974985,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.27,0.27,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8981214,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.91,0.91,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8986131,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KHM,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Cambodia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
8987366,GASP_ISOLATESDSR_PROPORTION,COUNTRY,THA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.20,0.2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Thailand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9006948,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.90,0.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9031635,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,42.00,42,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9038455,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,34.49,34.49,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9044741,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.00,8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9045360,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SLV,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,El Salvador,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9057038,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,9.80,9.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9062292,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9068719,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,13.50,13.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9069047,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,90.28,90.28,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9082343,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9082623,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MNG,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,14.64,14.64,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Mongolia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9115372,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MYS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Malaysia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9127123,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.99,2.99,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9133038,GASP_ISOLATESDSR_PROPORTION,COUNTRY,HUN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,23.80,23.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Hungary,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9139091,GASP_ISOLATESDSR_PROPORTION,COUNTRY,TUN,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CIP,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Tunisia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9139890,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UKR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Ukraine,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9159486,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_AZM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.74,8.74,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9170516,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,14.67,14.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9171498,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BHR,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_ESC,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Bahrain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9177696,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,36.94,36.94,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,China,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9184943,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CZE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,49.50,49.5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Czechia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9191181,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9215975,GASP_ISOLATESDSR_PROPORTION,COUNTRY,AUS,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,29.98,29.98,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Australia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9222781,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IRL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,18.18,18.18,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9235170,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9248039,GASP_ISOLATESDSR_PROPORTION,COUNTRY,COL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,54.10,54.1,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Colombia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9254764,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.56,5.56,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Switzerland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9274174,GASP_ISOLATESDSR_PROPORTION,COUNTRY,USA,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,22.32,22.32,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,United States of America,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9299060,GASP_ISOLATESDSR_PROPORTION,COUNTRY,EST,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Estonia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9305080,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9305879,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.00,5,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9310823,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PER,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,90.00,90,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Peru,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9317275,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IND,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.00,8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,India,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9342908,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,17.86,17.86,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9343297,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BFA,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_AZM,2019,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.90,3.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2019,2019-01-01T00:00:00+01:00,2019-12-31T00:00:00+01:00,Burkina Faso,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9354473,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CFM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.75,1.75,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9354787,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9354912,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,29.88,29.88,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9354918,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9374766,GASP_ISOLATESDSR_PROPORTION,COUNTRY,RUS,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Russian Federation,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9400693,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9405749,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9407280,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRY,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Paraguay,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9418005,GASP_ISOLATESDSR_PROPORTION,COUNTRY,DEU,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,13.90,13.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Germany,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9437650,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NLD,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Netherlands (Kingdom of the),Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9438175,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,8.33,8.33,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9438321,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_ESC,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.48,3.48,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9444777,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,96.88,96.88,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Pakistan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9475599,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,18.57,18.57,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9476880,GASP_ISOLATESDSR_PROPORTION,COUNTRY,PRT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,12.70,12.7,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Portugal,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9477199,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CAN,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_AZM,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,1.16,1.16,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Canada,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9481703,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GRC,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,5.88,5.88,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Greece,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9482127,GASP_ISOLATESDSR_PROPORTION,COUNTRY,FIN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,3.80,3.8,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Finland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9488462,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ITA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.00,2,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Italy,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9489605,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,39.00,39,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9501250,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LUX,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Luxembourg,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9502161,GASP_ISOLATESDSR_PROPORTION,COUNTRY,BEL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,44.44,44.44,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Belgium,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9513951,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVN,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Slovenia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9514222,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_ESC,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9514956,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MLT,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Malta,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9539352,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SVK,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2009,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.67,6.67,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2009,2009-01-01T00:00:00+01:00,2009-12-31T00:00:00+01:00,Slovakia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9552397,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LVA,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,10.00,10,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Latvia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9564084,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ESP,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_ESC,2013,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,15.13,15.13,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2013,2013-01-01T00:00:00+01:00,2013-12-31T00:00:00+01:00,Spain,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9566014,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2018,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2018,2018-01-01T00:00:00+01:00,2018-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9578801,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CZE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,6.70,6.7,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Czechia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9590866,GASP_ISOLATESDSR_PROPORTION,COUNTRY,JPN,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2015,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,25.08,25.08,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2015,2015-01-01T00:00:00+01:00,2015-12-31T00:00:00+01:00,Japan,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9609972,GASP_ISOLATESDSR_PROPORTION,COUNTRY,KOR,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,Republic of Korea,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9653526,GASP_ISOLATESDSR_PROPORTION,COUNTRY,CHL,YEAR,AMR,Americas,ANTIBIOTIC,ANTIBIOTIC_CIP,2012,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,30.90,30.9,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2012,2012-01-01T00:00:00+01:00,2012-12-31T00:00:00+01:00,Chile,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9666477,GASP_ISOLATESDSR_PROPORTION,COUNTRY,IDN,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CIP,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,100.00,100,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Indonesia,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9673367,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NOR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CIP,2011,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,32.47,32.47,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2011,2011-01-01T00:00:00+01:00,2011-12-31T00:00:00+01:00,Norway,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9698315,GASP_ISOLATESDSR_PROPORTION,COUNTRY,POL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Poland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9705276,GASP_ISOLATESDSR_PROPORTION,COUNTRY,SWE,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,7.14,7.14,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,Sweden,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9709731,GASP_ISOLATESDSR_PROPORTION,COUNTRY,MDG,YEAR,AFR,Africa,ANTIBIOTIC,ANTIBIOTIC_CRO,2016,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,2.86,2.86,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2016,2016-01-01T00:00:00+01:00,2016-12-31T00:00:00+01:00,Madagascar,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9716493,GASP_ISOLATESDSR_PROPORTION,COUNTRY,ISL,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CFM,2014,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2014,2014-01-01T00:00:00+01:00,2014-12-31T00:00:00+01:00,Iceland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9736231,GASP_ISOLATESDSR_PROPORTION,COUNTRY,LKA,YEAR,SEAR,South-East Asia,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Sri Lanka,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9756330,GASP_ISOLATESDSR_PROPORTION,COUNTRY,GBR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_AZM,2010,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.45,0.45,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2010,2010-01-01T00:00:00+01:00,2010-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9761190,GASP_ISOLATESDSR_PROPORTION,COUNTRY,NZL,YEAR,WPR,Western Pacific,ANTIBIOTIC,ANTIBIOTIC_CRO,2017,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0.44,0.44,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2017,2017-01-01T00:00:00+01:00,2017-12-31T00:00:00+01:00,New Zealand,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
9780760,GASP_ISOLATESDSR_PROPORTION,COUNTRY,UKR,YEAR,EUR,Europe,ANTIBIOTIC,ANTIBIOTIC_CRO,2020,NA,NA,NA,NA,DATASOURCE,DATASOURCE_WHOGASP,0,0,NA,NA,NA,2025-03-19T15:04:47.647+01:00,2020,2020-01-01T00:00:00+01:00,2020-12-31T00:00:00+01:00,Ukraine,Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion),EN,Antibiotic
